There are many opportunities to partner with us to find a cure for kidney cancer. Philanthropic support may be specifically directed to any of these projects, or given undesignated, which allows us to allocate funds wherever current needs are greatest. If your intent is for undesignated funds to be used to support the Kidney Cancer Program, please indicate so in the donation information.
Ensuring Innovative Research in Perpetuity
An endowed fund would serve as a significant and permanent source of support for the Kidney Cancer Program. Ranging from gift levels of $1 million to establish a Distinguished Chair to $10 million to name the Kidney Cancer Program and establish it as a Comprehensive Center, such funds would enable a permanent connection with the name of the donor - or someone the donor wishes to honor – with the excellence of UT Southwestern.
Leveraging the National Cancer Institute's (NCI) Specialized Program of Research Excellence (SPORE) Funding
While the SPORE award provides significant funding for innovative research on diagnostics and treatments for kidney cancer patients, it is only a portion of the total funding required to meet our ultimate goals.
Finding the Next Advancement in Immunotherapy
Our investigators are exploring exciting and effective methods of applying Nobel Prize-winning discoveries at UT Southwestern as well as innovative imaging modalities to enhance and tailor the body’s immune response to fight kidney cancer.
Career Development of Future Scientists
Provide critically needed support for early-career investigators, the future of kidney cancer research.
Find Better Treatments for Pediatric Patients
Current treatments for children are effective, but chemotherapy often leaves lifelong debilitating effects. Our research seeks to find better options and your philanthropy can help.
Bringing Big Data to Bear on the Concerns We Face Today
A major current challenge in kidney cancer research is our inability to collectively and broadly assess some fundamental questions (e.g., the inability to predict responses to therapies). Most drugs induce responses in 10 to 40 percent of patients, but a similar percentage of patients do not respond at all. By establishing both an in-house as well as an international registry to systematically collect and annotate kidney cancer specimens and pertinent data from thousands of patients, we can help reveal new answers.
Help Patients with Transportation or Other Needs
To receive their treatment and care at UT Southwestern, many patients travel long distances and some patients require financial assistance.
To learn more, contact UT Southwestern’s Office of Development at 214-648-2344 or firstname.lastname@example.org.